TrialLancet (London, England)2013

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study.

Marina Cuchel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.